Several cardiovascular outcome trials (CVOTs) have also reported that GLP-1 RAs may be associated with mitigating kidney-related outcomes, including albuminuria, decline in eGFR and the risk of end-stage kidney disease, independent of their effects on glycemic control 14,15,17,26,27
But for the right candidate, they can be life changing
They might also acquire traits that are required to overtake host tissue
You will start with lower doses for the first 4 weeks of treatment to help reduce initial stomach side effects, but this is not an effective dose to lower blood sugar over the long-term
Please consult a medical professional to determine whether or not GLP-1 medications could be appropriate for you.
If you want targeted nutritional support during treatment, GLP-1 Daily Support is designed to fit that need